Unibest
← Back to patent-cliff list

CAS 110-85-0

piperazinePiperazineDiethylenediamine1,4-Diazacyclohexane

Codes: PALB-042, OLAP-013, RIBO-012, BREX-006, VORT-004, Rifampicin-001, RANO-004, POSA-037, Urapidil-012

Physicochemical properties & identification

Appearance
White to colourless crystals or flakes; strongly hygroscopic, with an amine odour
Solubility
Very readily soluble in water and ethanol; a strong base (pKa1 ≈ 5.6 / pKa2 ≈ 9.8)
Storage
Seal under nitrogen and protect from moisture; keep away from acids and oxidising agents

Applications

  • · Pharmaceutical building block: the core amine source for piperazine-ring CNS drugs such as aripiprazole, brexpiprazole and cariprazine
  • · Raw material for the anthelmintic piperazine salts (citrate / phosphate)
  • · CO2 capture (activator in MDEA formulations); epoxy curing agent

Application context (from source-drug indications)

Breast cancerPalbociclibEndometrial cancerOlaparibCastration-resistant prostate cancerOlaparibProstate cancerOlaparibPeritoneal cancerOlaparibEpithelial ovarian cancerOlaparibFallopian tube cancerOlaparibBreast cancerRibociclib SuccinateSchizophreniaBrexpiprazoleAlzheimer's diseaseBrexpiprazoleAgitationBrexpiprazoleDepressionBrexpiprazoleDepressive disorderBrexpiprazoleMajor depressive disorderBrexpiprazoleMajor depressive disorderVortioxetine HydrobromidePostoperative painVortioxetine HydrobromideCannabis dependenceVortioxetine HydrobromideAnxietyVortioxetine HydrobromideAnxiety disorderVortioxetine HydrobromideDepressionVortioxetine HydrobromideMycobacterium tuberculosis infectionEthambutol Hydrochloride/Rifampicin/IsoniazidAngina pectorisRanolazineMyocardial infarctionRanolazineAmyotrophic lateral sclerosisRanolazineStable anginaRanolazineCrohn's diseaseRanolazineInflammatory bowel diseaseRanolazineCandidiasisPosaconazoleAspergillus infectionPosaconazoleFungal infectionPosaconazoleOral candidiasisPosaconazoleCoccidioidomycosisPosaconazoleHistoplasmosisPosaconazoleMycobacterium tuberculosis infectionRifampicinMycobacterium leprae infectionRifampicinPulmonary tuberculosisRifampicinMeningococcal meningitisRifampicinCOVID-19RifampicinRespiratory viral infectionRifampicinHypertensionUrapidil hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
PalbociclibTier A — Act now2027
OlaparibTier A — Act now2028
Ribociclib SuccinateTier A — Act now2029
BrexpiprazoleTier A — Act now2029
Vortioxetine HydrobromideTier B — Position early-
Ethambutol Hydrochloride/Rifampicin/IsoniazidTier C — Watch / trade-
RanolazineTier C — Watch / trade-
PosaconazoleTier C — Watch / trade-
RifampicinTier C — Watch / trade-
Urapidil hydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

BrexpiprazoleOriginator routesteps: 3total yield: 13.6 g
7-hydroxyquinolin-2(1H)-one→1-bromo-4-chlorobutane→7-(4-chlorobutoxy)quinolin-2(1H)-one→1-(benzo[b]thiophen-4-yl)piperazine hydrochloride→4-bromobenzo[b]thiophene→piperazine
Vortioxetine HydrobromideOriginator routesteps: 5total yield: 13.3 g
1,2-dichlorobenzene→VORT-002→VORT-003→piperazine→VORT-005→2,4-dimethylbenzenethiol→VORT-007
Vortioxetine HydrobromideProcess routesteps: 3total yield: 895 g

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site2-Fluoro-5-formylbenzonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]benzonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works2-fluoro-5-((4-oxo-3,4-dihydrophthalazin -1-yl)Methyl)benzoic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site1-(Cyclopropylcarbonyl)piperazine hydrochloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Workstert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteTert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Sitetert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksPD 0332991 HCl
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6- carboxamide
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.